On Bioartificial Liver Assist System

References

• Sussman N L, Lake J R. Treatment of hepatic failure - 1996, Current concept and progress forward liver dialysis Ameri. J Kid Dis 1996; 27(5)605–621
   PubMed Web of Science ®Google Scholar
• Watanabe F D, Mullon C J, Hewitt W R, Arkadopoulos N, Kahaku E, Eguchi S, Khalili T, Shacklenton C R, Rozga J, Solomon B, Demetriou A A. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann Surg 1997; 225(5)484–491
   PubMed Web of Science ®Google Scholar
• Gerlach J C. Long-term liver cell cultures in bioreactors and possible application for liver support. Cell Biol Toxicol 1997; 13(4–5)349–355
   PubMed Web of Science ®Google Scholar
• Kasai S, Sawa M, Mito M. Is the biological artificial liver clinically applicable? A historic review of biological artificial liver support systems. Artif Organs 1994; 18: 348–354
   PubMed Web of Science ®Google Scholar
• Nyberg S L, Peshwa M, Payne W D, Hu W S, Cerra F B. Evolution of the bioartificial liver: The need for randomized clinical trials. The Ameri J Surg 1993; 166: 513
   Web of Science ®Google Scholar
• Dixit V. Development of a bioartificial liver using isolated hepatocytes. Artif Organs 1994; 18: 371–384
   PubMed Web of Science ®Google Scholar
• Rozga J, Demetriou A A. Evolution and future perspective. ASAIO J 1995; 41: 831–837
   PubMedGoogle Scholar
• Jauregui H O. The technology of biological extracorporeal liver assist devices: from infancy to adolescence. Artif Organs 1997; 21(11)1163–1168
   PubMed Web of Science ®Google Scholar
• Atillasoy E, Berk P D. Fulminant hepatic failure: Pathophysiology, treament, and survival. Ann Rev Med 1995; 46: 181–191
   PubMed Web of Science ®Google Scholar
• Hughes R D, Williams R. Use of bioartificial and artificial liver support devices. Semi Liver Dis 1996; 16(4)435–444
   PubMed Web of Science ®Google Scholar
• Berk P D. Artificial liver: a baby delivered prematurely. Gastroenterology 1978; 74(4)789–91
   PubMed Web of Science ®Google Scholar
• Popp J A. Toxicologic pathology of the liver. Toxicologic Path 1996; 24(1)3
   PubMed Web of Science ®Google Scholar
• Galletti P M, Jauregui H O. Liver support system. The Biochemical Engineering Handbook, J D Bronzino, et al. CRC Press. 1995; 1952–66
   Google Scholar
• Jauregui H O, Chowdhury N R, Chowdhury J R. Use of mammalian liver cells for artificial liver support. Cell Transplantation 1995; 5: 353–367
   Web of Science ®Google Scholar
• Rauen U, Reuters I, Fuchs A, Groot H. Oxygen-free radical-mediated injury to cultured rat hepatocytes during cold incubation in preservation solutions. Hepatology 1997; 26: 351–357
   PubMed Web of Science ®Google Scholar
• Authur M J, Bentley I S, Tanner A R, Saunders P K, Millward S G H, Wright R. Oxygen-derived free radicals promote hepatic injury in rat. Gastroenterology 1995; 89(5)1114–1122
   Google Scholar
• Enosawa S, Suzuki S, Kakefuda T, Amemiya H. Examination of 7-ethoxycomarin deethylation and ammonia removal activities in 31 hepatocyte cell lines. Cell Transplatation 1996; 5(5S-1)39–46
   Google Scholar
• Hughes R D, Cochrane A M G, Thomson A D, Murray-Lyon I M, Williams R. The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes. Br J Exp Path 1976; 57: 348
   PubMedGoogle Scholar
• Gover C D, Hughes R D, Williams R. Rapid inhibition of DANN synthesis in hepatocytes from regenerating livers by serum from patients with fulminant hepatic failure. Br J Exp Path 1982; 63: 547–53
   PubMedGoogle Scholar
• Haas T, Holloway C J, Osterthum V, Trautschold I. Hepatotoxic effects of sera from patients with fulminant hepatitis B on isolated rat hepatocytes in culture. J Clin Chem Clin Biochem 1981; 19: 283–286
   PubMedGoogle Scholar
• Shi Q, Hayes P C, Grant M H. The effects of sreum from patients with acute liver failure on the growth and metabolism of Hep G2 cells. Artif Organs 1998, Submitted
   PubMed Web of Science ®Google Scholar
• Sewell R B, Hughes R D, Poston L, William's R. Effects of serum from patients with fulminant hepatic failure on leucocyte sodium transport. Clin Sci 1982; 63: 237–42
   PubMed Web of Science ®Google Scholar
• Ede R F, Williams R. Occurrence and management of cerebral edema in liver failure. Liver Failure, R William's. Churchill Livingstone Press. 1986; 26–46
   Google Scholar
• Williams R, Hughes R D, Cochrame A M, Ellis W R, Murray-Lyon I M. Studies on plasma cytotoxicity and liver regeneration in fulminant hepatic failure. Ciba Found Symp 1977; 55: 299–305
   Google Scholar
• Hughes R D, Yamada H, Gove C D, Williams R. Inhibition of hepatic DNA synthesis in fulminant hepatic failure. Dig Dis Sci 1991; 36(6)816–819
   PubMed Web of Science ®Google Scholar
• Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992; 59(5)1609–1623
   PubMed Web of Science ®Google Scholar
• Siems W G, Hapner S J, van Kuijk F S G M. 4-Hydroxynoneal inhibits Na-K-ATPase. Free Radi Biol Med 1996; 20(2)215–223
   PubMed Web of Science ®Google Scholar
• Losser M R, Payen D. Mechanisms of liver damage. Semi Liv Dis 1996; 16(4)357–367
   PubMed Web of Science ®Google Scholar
• Park D V, Ioannides C. Reactive intermediates and oxygen toxicity in liver injury. Mechanisms of hepatocyte injury and death, D Keppler, et al. MTP Press Limited. 1983; 37–48
   Google Scholar
• Kedderis G. Biochemical basis of hepatocellular injury. Toxicol Path 1996; 19(1)3–6
   Google Scholar
• Hu H L, Chen R D. Changes in free radicals, trace elements, and neurophysiological function in rats with liver damage induced by D-galactosamine. Biol Trace Elem Res 1992; 34(1)19–25
   PubMed Web of Science ®Google Scholar
• Evans J P, Evans R W, Bomford A, Williams R, Halliwell B. Metal ions catalytic for free radical reactions in the plasma of patients with fulminant hepatic failure. Free Radic Res 1994; 20(3)139–144
   PubMed Web of Science ®Google Scholar
• Saibara T, Himeno H, Onishi S, Yamamoto Y, Enzan H, Hara H, Takehara Y, Utsumi K. Acute hepatic failure with swollen mitochondria and microvesicular fatty degeneration of hepatocytes triggered by free radical initiator. Lab Invest 1994; 70(4)517–524
   PubMed Web of Science ®Google Scholar
• Biasi F, Chiaropotto E, Lanfranco G, Capra A, Zummo U, Chiappino I, Scavazza A, Albano E, Poli G. Oxidative stress in the development of human ischemic hepatitis during circulatory shock. Free Radic Biol Med 1994; 17(3)225–233
   PubMed Web of Science ®Google Scholar
• Takahashi K, Ogura Y, Kawarada Y. Pathophysiological changes caused by occlusion of blood flow into the liver during hepatectomy in dogs with obstructive jaundice: effects of intestinal congestion. J Gastroenterol Hepatol 1996; 11(10)963–70
   PubMed Web of Science ®Google Scholar
• Arnaiz S L, Llesuy S, Cutrin J C. Oxidative stress by aute acetaminophen administration in mouse liver. Free Radi Biol Med 1995; 19(3)303–310
   PubMed Web of Science ®Google Scholar
• Casini A, Ceni E, Salzano R, Biondi P, Parola M, Gahi A, Foschi M, Caligiuri A, Pinzani M, Surrenti C. Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. Hepatology 1997; 25: 361–367
   PubMed Web of Science ®Google Scholar
• Brent J A, Rumack B H. Role of free radicals in toxic hepatic injury. I. Free radical biochemistry. J Toxicol Clin Toxicol 1993; 31(1)139–171
   PubMed Web of Science ®Google Scholar
• Gove C D, Hughes R D, Ede R J, Williams R. Regional cerebral edema and chloride space in galactosamine-induced liver failure in rats. Hepatology 1997; 25(2)295–301
   PubMed Web of Science ®Google Scholar
• Markesbery W R. Oxidative stress hypothesis in Alzeimer disease. Free Radic Biol Med 1997; 23(1)134–147
   PubMed Web of Science ®Google Scholar
• Tan S, Adams M M, Royall J, Freeman B A, Parks D A. Endothelial injury from a circulating mediator following rat liver ischemia. Free Radic Biol Med 1998; 24(3)427–434
   PubMed Web of Science ®Google Scholar
• Kay M A, Fausto N. Liver regeneration: prospects for therapy based on new technologies. Mol Med Today March, 1997; 108–115
   PubMedGoogle Scholar
• Hughes R D, Williams R. Assessment of bioartificial liver support in acute liver failure. Int J Artif Orgns 1996; 19(1)3–6
   PubMed Web of Science ®Google Scholar
• Ash S R. Treatment of acute hepatic failure with encephalopathy. A review Int J Artif Organs 1991; 14: 191–195
   PubMed Web of Science ®Google Scholar
• Stange J, Mitzner S. A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patient blood and a bioartificial liver. Int J Artif Organs 1996; 19(11)677–691
   PubMed Web of Science ®Google Scholar
• Burt A D, Fames U F W. Pathophysiology of the liver. Pathology of the liver, R NM MacSweem, et al. Churchill Livingstone Press. 1994
   Google Scholar
• Cadenas E, Sies H. Free radicals in lipid peroxidation and prostagladin formation:role of glutathione. Mechanisms of hepatocyte injury and death, D Keppler, et al. MTP Press Limited. 1983; 163–173
   Google Scholar
• Nishida K, Ohta Y, Ishiguro I. Modulating role of endogenous reduced glutathione in TERI-butyl hydroperoxide-induced cell injury in isolated rat hepatocytes. Free Radic Biol Med 1997; 23(3)453–462
   PubMed Web of Science ®Google Scholar
• Zhu H, He M, Bannenberg Gl., Moldeus P, Shertzer H G. Effects of glutathione and pH on the oxidation of biomarkers of cellular oxidative stress. Arch Toxicol 1996; 70: 628–634
   PubMed Web of Science ®Google Scholar
• Moldeus P, Jernstrom B. Interaction of glutathione with reactive intermediates. Functions of glutathione: Biochemical, physiological, toxicological anf clinical aspects, A Larsson, et al. Raven Press, New York 1983; 99–107
   Google Scholar
• Meister A. The liver:Biology and Pathology, M Arias, et al. Raven Press, Ltd., New York 1988; 401–417
   Google Scholar
• Kretzschmar M. Regulation of hepatic glutathione metabolism and its control in hepatoxicity. Exp Toxicol Pathol 1996; 48(5)439–46
   PubMedGoogle Scholar
• Dirven H A, Megens L, Oudshoorn M J, Dinggemanse M A, van-Ommen B, van-Bladeren P J. Glutathione conjugation of alkylatioting cytostatic drugs with a nitrogen mustard group and the role of glutathione-S-transferase. Chem res Toxicol 1995; 8(7)979–86
   PubMed Web of Science ®Google Scholar
• Puri R N, Meister A. Transport of glutathione, as (-glutamylcysteinyglucyl ester, into liver and kidney. Proc Natl Acad Sci USA 1983; 80: 5258–5260
   PubMed Web of Science ®Google Scholar
• Anderson M E. Glutathione and glutathione delivery compounds. Adv. Pharmacol 1997; 38: 65–78
   PubMedGoogle Scholar
• Hayes J D, Pulford D J. The glutathione S-transferase supergene family:reglaton of GST and the constribution of the iosenzymes to cancer chemoprotection and drug resistance. Crit Rew Biochem Mol Biol 1995; 30(6)445–600
   PubMed Web of Science ®Google Scholar
• Lii C K, Wang S T, Chen H W, Sheen L Y. Glutathione and glutathione-related enzymes activities of male and female rat hepatocytes under various culture conditions. Arch Toxicol 1996; 70(12)822–829
   PubMed Web of Science ®Google Scholar